| 1 |
NCT03448380 |
Recruiting |
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study |
|
- Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Safety of the FreeStyle Libre Flash Glucose Monitoring System
|
920 |
All |
18 Years and older (Adult, Senior) |
NCT03448380 |
ADC-US-PMS-17168-001 |
|
February 27, 2018 |
March 2021 |
March 2021 |
February 28, 2018 |
March 1, 2018 |
|
- Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 2 |
NCT03440073 |
Enrolling by invitation |
Intervention for Pregnancy Related Pain |
- Other Specified Pregnancy-Related Conditions
|
- Other: Mulligan Concept Intervention
- Other: Sham Mulligan Concept Treatment
|
Interventional |
Not Applicable |
- University of Idaho
- National Institutes of Health (NIH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- 3-D motion Analysis- sit to stand
- 3-D Motion Analysis- gait
- 3-D Motion Analysis- active straight leg raise
- (and 7 more...)
|
36 |
Female |
20 Years to 45 Years (Adult) |
NCT03440073 |
17-042
18-22QR-UI-PG76 |
|
January 10, 2018 |
March 2, 2018 |
March 2, 2018 |
February 20, 2018 |
February 20, 2018 |
|
- Integrated Sport Medicine and Rehabilitative Therapy Clinic
Moscow, Idaho, United States
|
| 3 |
NCT02940587 |
Withdrawn |
Effectiveness of Aurix Therapy in Venous Leg Ulcers |
|
|
Interventional |
Phase 4 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Time to Heal
- Proportion of wounds healed
- Change in Quality of Life with Chronic Wounds (W-QOL) Score
|
0 |
All |
18 Years and older (Adult, Senior) |
NCT02940587 |
CM003 Gold |
|
February 2015 |
February 2018 |
February 2018 |
October 21, 2016 |
October 21, 2016 |
|
- St. Luke's Intermountain Research
Boise, Idaho, United States
|
| 4 |
NCT02921009 |
Recruiting |
McNeel Eye Center Corneal Crosslinking Study |
|
- Device: Crosslinking using UV light of two different fluence rates
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Post treatment topographic analysis of Crosslinked patients
- Post Treatment Best Corrected Visual Acuity
|
100 |
All |
15 Years to 50 Years (Child, Adult) |
NCT02921009 |
MEC CxL Transepithelial |
|
September 2016 |
December 2018 |
December 2018 |
September 30, 2016 |
March 22, 2018 |
|
- McNeel Eye Center
Boise, Idaho, United States
|
| 5 |
NCT02912351 |
Recruiting |
A Post-Market Retrospective Study on Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis |
|
- Other: Patient record review, Radiographs, and questionaires.
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Total Knee Society Scores (KSS)
- Radiographic Analysis
- Patient Satisfaction
- Complication Assessment
|
50 |
All |
Child, Adult, Senior |
NCT02912351 |
K102437-01 |
|
January 2017 |
December 2018 |
December 2018 |
September 23, 2016 |
May 25, 2017 |
|
- Saint Alphonsus Medical Group
Boise, Idaho, United States
|
| 6 |
NCT02900248 |
Recruiting |
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice |
- Neoplasms
- Lung Neoplasms
- Colon Neoplasms
- (and 22 more...)
|
- Other: Provider determined
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Best Overall Response
- Time to Treatment Progression
- Overall Survival
- (and 2 more...)
|
100000 |
All |
18 Years and older (Adult, Senior) |
NCT02900248 |
N1OR |
N1 |
October 2, 2017 |
October 2021 |
October 2024 |
September 14, 2016 |
October 4, 2017 |
|
- Teton Cancer Institute
Idaho Falls, Idaho, United States
|
| 7 |
NCT02632929 |
Active, not recruiting |
Prevention of Amputation in Diabetic Foot Ulcers Using Amniotic Tissue |
|
|
Observational |
|
- Boise VA Medical Center
- Integra LifeSciences Corporation
|
U.S. Fed / Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Limb salvage
- effective wound healing
|
20 |
All |
18 Years and older (Adult, Senior) |
NCT02632929 |
00816 |
|
July 2015 |
July 2019 |
September 2019 |
December 17, 2015 |
January 19, 2018 |
|
- Boise VAMC
Boise, Idaho, United States
|
| 8 |
NCT02363907 |
Completed
Has Results |
Observational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in Pediatrics |
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Point Accuracy of CGM ISF Readings to Blood Glucose Measured by a Reference Device
|
30 |
All |
2 Years to 17 Years (Child) |
NCT02363907 |
PTL-900982 |
|
September 2012 |
October 2012 |
October 2012 |
February 16, 2015 |
July 27, 2017 |
July 27, 2017 |
- Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 9 |
NCT02330445 |
Completed |
6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection |
|
|
Interventional |
Phase 1
Phase 2 |
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety (Analysis of Adverse Events)
- ACR-28 joint count
- Patient's global assessment of disease activity
- (and 14 more...)
|
13 |
All |
18 Years and older (Adult, Senior) |
NCT02330445 |
PRTX-100-105 |
SPARTA-II |
February 2015 |
April 2016 |
April 2016 |
January 5, 2015 |
April 19, 2017 |
|
- Protalex Investigational Site
Coeur d'Alene, Idaho, United States
|
| 10 |
NCT02230085 |
Completed
Has Results |
Adherence Risk Indicator Validation Study |
|
- Other: Administration of the questionnaire and monitoring of CPAP adherence
|
Observational |
|
- Fisher and Paykel Healthcare
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
110 |
All |
18 Years and older (Adult, Senior) |
NCT02230085 |
CIA-121 |
ARI |
September 2014 |
August 2015 |
December 2015 |
September 3, 2014 |
March 3, 2017 |
December 2, 2016 |
- EverythingCPAP
Boise, Idaho, United States
|
| 11 |
NCT02185001 |
Terminated |
Repair of Medial Patellofemoral Ligament Compared to Conservative Treatment for First Time Patella Dislocation |
- Dislocated Patella
- Torn Medial Patellofemoral Ligament
|
- Procedure: Direct Medial Patellofemoral Ligament (MPFL) Repair
- Procedure: Physical therapy
|
Interventional |
Not Applicable |
- Orthopedic Specialty Institute
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Patient Reported Change in Patellar Stability, Subluxation, or Recurrent Dislocation.
- Subjective Outcome Measurement (Kujala Test)
|
2 |
All |
10 Years and older (Child, Adult, Senior) |
NCT02185001 |
TLKC-0001 |
|
October 2014 |
March 2016 |
March 2016 |
July 9, 2014 |
March 9, 2017 |
|
- The Lyman Knee Clinic
Coeur d'Alene, Idaho, United States
|
| 12 |
NCT02170558 |
Recruiting |
Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With TM-Ardis |
- Degenerative Disc Disease
|
- Device: TM- Ardis implant and Metal Reduction CT software
|
Observational |
|
|
Industry |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- CT scan to determine if the study software can reduce metal scatter on the scan.
|
35 |
All |
18 Years to 85 Years (Adult, Senior) |
NCT02170558 |
CSU2013-05S |
|
June 2014 |
December 2018 |
December 2018 |
June 23, 2014 |
March 15, 2016 |
|
- St Alphonsus Regional Medical Center
Boise, Idaho, United States
|
| 13 |
NCT02121769 |
Available |
Omegaven Expanded Access Protocol |
- Parenteral Nutrition Associated Liver Disease
|
|
Expanded Access |
|
- St. Luke’s Health System, Boise, Idaho
|
Other |
|
|
|
All |
up to 17 Years (Child) |
NCT02121769 |
Omegaven Expanded Access |
|
|
|
|
April 24, 2014 |
October 10, 2017 |
|
- St. Luke's Pediatric Gastroenterology
Boise, Idaho, United States
|
| 14 |
NCT02091804 |
Active, not recruiting |
Beginning Relationships in a Native Community |
|
- Behavioral: Immediate Group
- Behavioral: Wait-List group
|
Interventional |
Not Applicable |
- University of Washington
- National Institute on Minority Health and Health Disparities (NIMHD)
- Washington State University
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Other
|
- Change in Quality of caregiver-child interactions from baseline at 3 months and 6 months
- Change in Caregiver helplessness from baseline at 3 months and 6 months
- Change in Caregiver stress from baseline at 3 months and 6 months
- Change in Child Social-emotional Competence from baseline at 3 months and 6 months
|
34 |
All |
Child, Adult, Senior |
NCT02091804 |
45360
1P20MD006871 |
P20-RP3 |
September 2014 |
May 2017 |
May 2018 |
March 19, 2014 |
October 26, 2017 |
|
- Nimiipuu Health Community Clinic
Lapwai, Idaho, United States
|
| 15 |
NCT01544283 |
Unknown † |
Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome |
|
- Drug: Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch
- Drug: Triamcinolone Acetonide
|
Interventional |
Phase 2 |
- Injury Care Medical Center
- Nuvo Research Inc.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Pain Intensity
- Patient Global Assessment of Treatment Satisfaction
- Patient Global Impression of Change
- (and 2 more...)
|
60 |
All |
18 Years and older (Adult, Senior) |
NCT01544283 |
NS001 |
|
March 2012 |
January 2014 |
March 2014 |
March 5, 2012 |
March 6, 2012 |
|
- Injury Care Medical Center
Boise, Idaho, United States
|
| 16 |
NCT01514305 |
Completed |
Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System |
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- Absolute Relative Difference (%) to Reference Standard
|
21 |
All |
18 Years and older (Adult, Senior) |
NCT01514305 |
PTL900830 |
|
November 2011 |
December 2011 |
December 2011 |
January 23, 2012 |
January 23, 2012 |
|
- Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 17 |
NCT01341067 |
Completed
Has Results |
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes |
|
|
Observational |
|
- Rocky Mountain Diabetes and Osteoporosis Center
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Change in HgbA1c
- Percentage of Time Spent at Glycemic Levels <65 mg/dl
- Change in Percentage of Time Spent at Glycemic Levels >180 mg/dl
- Change in Basal Insulin Dose From Baseline Values
|
30 |
All |
18 Years and older (Adult, Senior) |
NCT01341067 |
RMDC-001 |
DexlonT2 |
April 2011 |
December 2011 |
December 2011 |
April 25, 2011 |
May 2, 2014 |
May 2, 2014 |
- Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 18 |
NCT01084824 |
Completed |
A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin |
|
- Drug: Liquid nitrogen and cantharidin
- Drug: Liquid nitrogen and topical placebo
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Percentage of common warts cleared
|
70 |
All |
18 Years to 65 Years (Adult) |
NCT01084824 |
NID-001 |
|
June 2007 |
June 2008 |
September 2008 |
March 11, 2010 |
March 11, 2010 |
|
- North Idaho Dermatology
Coeur D'Alene, Idaho, United States
|
| 19 |
NCT01055444 |
Completed |
Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome |
- Shoulder Impingement Syndrome
|
- Drug: Heated lidocaine and tetracaine topical patch
|
Interventional |
Phase 2 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Pain intensity
- Pain interference with activities (general, normal work, and sleep)
|
20 |
All |
18 Years and older (Adult, Senior) |
NCT01055444 |
SC-202 |
|
March 2010 |
August 2010 |
September 2010 |
January 25, 2010 |
March 16, 2012 |
|
- Injury Care Medical Center
Boise, Idaho, United States
|
| 20 |
NCT00925353 |
Completed
Has Results |
The Pharmacokinetics of 4% Lidocaine Gel When Applied Topically to the Breasts |
|
|
Interventional |
Phase 4 |
- Mountain States Tumor and Medical Research Institute
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Pharmacokinetic Parameters Based on Plasma Concentration of Lidocaine and MEGX in Nanograms/Milliliter.
- EKG Changes
- Variation of Heart Rate (Bpm), Respiratory Rate (Respirations Per Minute, Rpm), Systolic Blood Pressure (mm Hg), and Diastolic Blood Pressure (mm Hg) Over Time.
- Frequencies of Moderate, Severe, or Life-threatening Side Effects
|
13 |
Female |
35 Years and older (Adult, Senior) |
NCT00925353 |
MSTMRI-002 |
|
January 2010 |
February 2010 |
February 2010 |
June 22, 2009 |
December 23, 2013 |
December 23, 2013 |
- St. Luke's Mountain States Tumor Institute
Boise, Idaho, United States
|
| 21 |
NCT00780741 |
Completed
Has Results |
Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months Old |
- Nasolacrimal Duct Obstruction
|
- Procedure: Immediate Office Probing
- Procedure: Deferred Facility Probing
|
Interventional |
Phase 3 |
- Jaeb Center for Health Research
- National Eye Institute (NEI)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Proportion of Participants With Treatment Success
- Cost of Treatment
- Months of Symptoms of Nasolacrimal Duct Obstruction (NLDO) Between Randomization and 18 Months of Age
- (and 2 more...)
|
220 |
All |
6 Months to 10 Months (Child) |
NCT00780741 |
NEI-142
2U10EY011751 |
NLD3 |
October 2008 |
November 2011 |
January 2012 |
October 28, 2008 |
June 24, 2016 |
November 12, 2012 |
- Intermountain Eye Centers
Boise, Idaho, United States
|
| 22 |
NCT00426933 |
Completed |
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections |
|
- Drug: Daptomycin
- Drug: Vancomycin
|
Interventional |
Phase 2 |
- Cubist Pharmaceuticals LLC
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Clinical Response Rate at TOC
- difference between clinical response rates at EOT
- microbiological eradication rates
|
100 |
All |
18 Years to 85 Years (Adult, Senior) |
NCT00426933 |
DAP-HDSD-06-01 |
|
January 2007 |
September 2007 |
September 2007 |
January 25, 2007 |
September 14, 2010 |
|
- Idaho Falls Infectious Diseases, PLLC
Idaho Falls, Idaho, United States
|
| 23 |
NCT00382083 |
Completed |
Premedication to Reduce Discomfort With Screening Mammography |
|
- Drug: 1000 mg acetaminophen
- Drug: 800 mg ibuprofen
- Drug: 1 oz 4% lidocaine gel
|
Interventional |
Phase 4 |
- Mountain States Tumor and Medical Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Double
- Primary Purpose: Treatment
|
- Discomfort scores on a visual analog scale at recruitment, at enrollment, and after mammogram
- Satisfaction scores on a visual analog scale after mammogram
- Pre-mammogram anxiety scores on a visual anxiety scale at enrollment
- Pre-mammogram breast tenderness scores on a visual analog scale at enrollment
|
|
Female |
30 Years and older (Adult, Senior) |
NCT00382083 |
MSTMRI - 001 |
|
March 2006 |
|
June 2006 |
September 28, 2006 |
September 28, 2006 |
|
- St. Luke's Mountain States Tumor Institute Breast Cancer Detection Center
Boise, Idaho, United States
|
| 24 |
NCT02925442 |
Enrolling by invitation |
Genicular Radiofrequency Ablation for Unilateral Knee Arthroplasty Pain Management |
- Osteoarthritis of the Knee
|
- Procedure: t-RFA
- Procedure: C-RFA
- Procedure: Control
|
Interventional |
Not Applicable |
- Lyman Medical Research Foundation, Inc.
- Halyard Health
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Postoperative analgesic consumption
- Hospital Length of Stay (LOS)
- Pain Score
|
150 |
All |
40 Years and older (Adult, Senior) |
NCT02925442 |
OSI-0002 |
RFA |
January 25, 2017 |
December 2018 |
December 2018 |
October 5, 2016 |
October 16, 2017 |
|
- Orthopedic Specialty Institute
Coeur d'Alene, Idaho, United States - Orthopedic Specialty Institute
Spokane, Washington, United States
|
| 25 |
NCT02021955 |
Active, not recruiting |
Integrating Care After Exacerbation of COPD |
- Chronic Obstructive Pulmonary Disease
|
- Behavioral: guideline treatment recommendations
|
Interventional |
Not Applicable |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- hospital re-admission and mortality
- patient quality-of-life
|
465 |
All |
Child, Adult, Senior |
NCT02021955 |
IIR 12-130 |
InCasE |
February 11, 2015 |
May 29, 2018 |
May 29, 2018 |
December 27, 2013 |
April 5, 2018 |
|
- Boise VA Medical Center, Boise, ID
Boise, Idaho, United States - VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, United States
|
| 26 |
NCT03448367 |
Recruiting |
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients |
|
- Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Safety of the FreeStyle Libre Flash Glucose Monitoring System
|
400 |
All |
4 Years to 17 Years (Child) |
NCT03448367 |
ADC-US-PMS-17168-002 |
|
February 27, 2018 |
February 2021 |
February 2021 |
February 28, 2018 |
April 10, 2018 |
|
- Sansum Diabetes Research Institute
Santa Barbara, California, United States - Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 27 |
NCT03077256 |
Recruiting |
Burst Biologics Foot and Ankle Registry |
- Foot and Ankle Disorders
- Ankle Fusion, Osteotomy
|
- Device: BioBurst Fluid, Burst Allograft
|
Observational |
|
- Burst Biologics
- Smart-Surgical Inc. dba Burst Biologics
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Fusion (%) Number of fusion patients fused/all fusion patients operated
- Bone Consolidation (%) Number of osteotomy patients with bone consolidation/all osteotomy patients operated
- Visual Analog Scale (VAS)
- (and 3 more...)
|
300 |
All |
18 Years and older (Adult, Senior) |
NCT03077256 |
FA002 |
|
March 24, 2017 |
July 1, 2018 |
October 1, 2018 |
March 10, 2017 |
April 17, 2018 |
|
- Georgetown University Medical Center
Washington, District of Columbia, United States - Rocky Mountain Foot and Ankle
Caldwell, Idaho, United States
|
| 28 |
NCT01839864 |
Withdrawn |
Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial |
|
- Behavioral: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count
|
Interventional |
Not Applicable |
- Family Medicine Residency of Idaho
- Mountain States Group
- Saint Alphonsus Medical Group
- Quantified, Inc.
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Patient Activation Measure from baseline to six months and six months to one year
- Changes in patient attitudes about providers and carefrom baseline to six months and six months to one year
|
0 |
All |
18 Years and older (Adult, Senior) |
NCT01839864 |
FMRI Promotora Trial |
FMRIMetSynd |
September 2013 |
June 2016 |
August 2016 |
April 25, 2013 |
February 14, 2017 |
|
- Saint Alphonsus Medical Group Caldwell Clinic
Caldwell, Idaho, United States - Saint Lukes Clinic Jerome
Jerome, Idaho, United States - St Alphonsus Medical Group Nampa Clinic
Nampa, Idaho, United States
|
| 29 |
NCT02109107 |
Completed
Has Results |
Study of Low Level Laser Light Therapy on Circumference Reduction |
|
- Device: Erchonia EZ6 Laser
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Combined Circumference Measurements
- Change in Body Weight
- Change in Body Mass Index (BMI)
- Subject Satisfaction With Study Outcome Rating
|
54 |
All |
18 Years to 65 Years (Adult) |
NCT02109107 |
EC_EZ6_BC_001 |
|
October 2013 |
November 2014 |
November 2014 |
April 9, 2014 |
February 2, 2016 |
February 2, 2016 |
- Advanced Gynecology Specialists of Augusta, LLC
Evans, Georgia, United States - CT Dermatology PC
Fruitland, Idaho, United States
|
| 30 |
NCT01835743 |
Completed
Has Results |
Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis |
|
- Device: Erchonia HPS Laser
- Device: Placebo Laser
|
Interventional |
Not Applicable |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Number of Participants Who Attained a Change of -30% or Greater in the VAS Score
- Change in Heel Pain Score on the Visual Analog Scale (VAS)
|
69 |
All |
18 Years and older (Adult, Senior) |
NCT01835743 |
EC_HP_001 |
|
February 2012 |
May 2012 |
May 2013 |
April 19, 2013 |
June 3, 2014 |
June 3, 2014 |
- Arizona Institute of Footcare Physicians
Mesa, Arizona, United States - Coughlin Foot and Ankle Clinic
Boise, Idaho, United States
|
| 31 |
NCT01704157 |
Completed |
A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device |
- Osteoarthritis of the Knee
|
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- An improvement in the Visual Analog Scale (VAS) for pain at Day 7
- Improvement (pain, stiffness, and functionality) as determined by WOMAC Scale at Day 7.
- Duration of Treatment Effect
- Analgesic Use
|
33 |
All |
18 Years and older (Adult, Senior) |
NCT01704157 |
MYO-0601
Pain-OA |
|
September 2012 |
April 2013 |
July 2013 |
October 11, 2012 |
January 29, 2014 |
|
- Neurovations
Napa, California, United States - Injury Care Medical Center
Boise, Idaho, United States
|
| 32 |
NCT00129831 |
Completed |
Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) |
|
|
Interventional |
Phase 2 |
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety variables (laboratory tests, ECG, adverse events)
- Lung function tests
- Pharmacokinetics
|
6 |
All |
40 Years to 75 Years (Adult, Senior) |
NCT00129831 |
CQAB149B2202 |
|
September 2004 |
September 2005 |
September 2005 |
August 12, 2005 |
October 25, 2011 |
|
- Radiant Research
Encinitas, California, United States - Radiant Research
Boise, Idaho, United States
|
| 33 |
NCT03015805 |
Recruiting |
Teen Success Project |
|
- Behavioral: Contingency Management
- Behavioral: Probation as Usual
|
Interventional |
Not Applicable |
- Oregon Social Learning Center
- George Mason University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes from Baseline scores compared to 9 months post-Baseline Urine Drug Screens (measured at 0, 3, 6 and 9 months).
- Changes from Baseline scores compared to 9 months post-Baseline Substance Use and Problems (measured at 0, 3, 6 and 9 months).
- Changes in number and severity of criminal charges in official records in the 18 months pre-Baseline compared with 18 months post-Baseline.
- (and 8 more...)
|
540 |
All |
12 Years to 17 Years (Child) |
NCT03015805 |
R01DA041434-01 |
JPO-CM |
October 1, 2017 |
November 2019 |
January 2021 |
January 10, 2017 |
April 5, 2018 |
|
- Mini-Cassia Juvenile Probation
Rupert, Idaho, United States - Twin Falls Juvenile Probation
Twin Falls, Idaho, United States - Washoe County Juvenile Probation
Reno, Nevada, United States
|
| 34 |
NCT02351115 |
Completed |
Staccato Alprazolam and Photoparoxysmal Response |
|
- Drug: Staccato® Alprazolam, 0.5 mg
- Drug: Staccato® Alprazolam, 1 mg
- Drug: Staccato® Alprazolam, 2 mg
- (and 2 more...)
|
Interventional |
Phase 2 |
- Alexza Pharmaceuticals, Inc.
- The Epilepsy Study Consortium
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in the photosensitivity response in subjects receiving Staccato® Alprazolam as compared to placebo
- Assessment of sedation using 2 visual analogue scales
- Correlation of plasma concentrations of Staccato® Alprazolam with pharmacodynamic effects on photosensitivity response
- Correlation of plasma concentrations of Staccato® Alprazolam with pharmacodynamic effects on sedation
|
5 |
All |
18 Years to 60 Years (Adult) |
NCT02351115 |
AMDC-002-202 |
|
January 2015 |
March 2016 |
March 2016 |
January 30, 2015 |
March 15, 2017 |
|
- Consultants in Epilepsy & Neurology, PLLC
Boise, Idaho, United States - New York University Epilepsy Center
New York, New York, United States - University of Pennsylvania - Penn Epilepsy Center
Philadelphia, Pennsylvania, United States
|
| 35 |
NCT02248636 |
Recruiting |
Cholinesterase Inhibitor Discontinuation |
|
- Drug: Cholinesterase inhibitor
- Drug: Sham discontinuation
|
Interventional |
Phase 2
Phase 3 |
- VA Office of Research and Development
|
U.S. Fed |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Successful completion
- Medical events
- Caregiver burden
- (and 4 more...)
|
100 |
All |
60 Years and older (Adult, Senior) |
NCT02248636 |
CLIN-014-13F |
CID |
January 22, 2015 |
May 1, 2019 |
July 1, 2019 |
September 25, 2014 |
January 12, 2018 |
|
- Boise VA Medical Center, Boise, ID
Boise, Idaho, United States - Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
Bedford, Massachusetts, United States - VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, United States
|
| 36 |
NCT01831960 |
Completed |
An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris |
|
- Drug: cortexolone 17α-propionate
|
Interventional |
Phase 2 |
- Intrepid Therapeutics, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in HPA Axis Response to Cosyntropin
- Change in PK profiles of cortexolone 17α-propionate and cortexolone
|
42 |
All |
12 Years and older (Child, Adult, Senior) |
NCT01831960 |
171-7151-202 |
|
April 2013 |
November 2013 |
November 2013 |
April 15, 2013 |
April 16, 2015 |
|
- Northwest Clinical Trials, Inc.
Boise, Idaho, United States - Shideler Clinical Research Center
Carmel, Indiana, United States - Michigan Center for Research Corp.
Clinton Township, Michigan, United States
|
| 37 |
NCT01175889 |
Unknown † |
Megadyne Ace Incision/Dissection Study |
- Abdominoplasty
- Bilateral Breast Reduction
- Bilateral Breast Lift
- (and 2 more...)
|
- Device: E-Z Clean ACE Blade
|
Interventional |
Phase 4 |
- Megadyne Medical Products Inc.
|
Industry |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Evaluate Wound Healing/Scar Formation
- Evaluate patient satisfaction relating to wound healing
|
52 |
All |
18 Years to 60 Years (Adult) |
NCT01175889 |
ACE MS 1 |
ACE |
August 2010 |
December 2012 |
December 2012 |
August 5, 2010 |
October 25, 2012 |
|
- Center for Plastic Surgery
Twin Falls, Idaho, United States - Southwest Surgical Suites, LLC
Fort Wayne, Indiana, United States - Plastic and Reconstructive Surgery University Health Sciences
Winston-Salem, North Carolina, United States
|
| 38 |
NCT03502174 |
Recruiting
New |
FreeStyle Libre Glucose Monitoring System in Pediatric Populations |
|
- Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- FreeStyle Libre Flash Glucose Monitoring System Performance
- FreeStyle Libre Flash Glucose Monitoring System Related adverse device effects
|
85 |
All |
6 Years to 17 Years (Child) |
NCT03502174 |
ADC-US-VAL-18172 |
|
April 5, 2018 |
August 2018 |
August 2018 |
April 18, 2018 |
April 18, 2018 |
|
- Sansum Diabetes Research Institute
Santa Barbara, California, United States - Diablo Clinical Research
Walnut Creek, California, United States - Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States
|
| 39 |
NCT00860093 |
Terminated |
Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy |
|
- Other: placebo
- Drug: MPC-5971
|
Interventional |
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- stone free rate after SWL treatment
- increase in urine inhibitors
- Reduced need for secondary procedures such as URS to clear obstructive fragments
- reduced stone/fragment area (mm2),percent change from the treatment stone area (mm2)
|
135 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT00860093 |
MPC-5971 |
|
April 2010 |
November 2010 |
December 2010 |
March 11, 2009 |
March 22, 2017 |
|
- Idaho Urologic Institute
Meridian, Idaho, United States - Columbus Urology Research
Columbus, Ohio, United States - Urology Clinics of North Texas, PA
Dallas, Texas, United States
|
| 40 |
NCT01753765 |
Completed |
Study Evaluating the Treatment of Occipital Neuralgia |
|
- Device: Device: Cryo-Touch III Study treatment at Day 0.
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- A reduction in either pain frequency or severity associated with occipital neuralgia.
- Duration of treatment
- Analgesic use
- Safety Events
|
26 |
All |
18 Years and older (Adult, Senior) |
NCT01753765 |
MYO-0613 |
|
October 2012 |
December 2013 |
July 2014 |
December 20, 2012 |
October 21, 2015 |
|
- Neurovations
Napa, California, United States - Injury Care Medical Center
Boise, Idaho, United States - International Clinical Research
Overland Park, Kansas, United States
|
| 41 |
NCT00328445 |
Completed |
Randomized Trial of the Positive Action Program in Hawaii Schools |
- Character
- Violence
- Substance Use
- (and 2 more...)
|
- Behavioral: Positive Action
|
Interventional |
Not Applicable |
- National Institute on Drug Abuse (NIDA)
|
NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Self-reported attitudes and behaviors
- Teacher reports of behaviors
- Parent reports of student behaviors
- (and 3 more...)
|
2500 |
All |
6 Years and older (Child, Adult, Senior) |
NCT00328445 |
R01DA013474 |
|
April 2001 |
June 2006 |
June 2006 |
May 22, 2006 |
January 12, 2017 |
|
- Positive Action, Inc.
Twin Falls, Idaho, United States - University of Illinois at Chicago
Chicago, Illinois, United States - Oregon State University
Corvallis, Oregon, United States
|
| 42 |
NCT00717522 |
Terminated
Has Results |
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma |
|
|
Interventional |
Phase 2 |
- Celgene Corporation
- Celgene
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of Participants With Adverse Events (AEs), Serious Adverse Events (SAEs), Deaths, or Discontinuations Due to AEs
- Tumor Response as Assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) Committee Guidelines
|
7 |
All |
18 Years and older (Adult, Senior) |
NCT00717522 |
CC-4047-STSAR-001 |
|
August 2008 |
January 2009 |
January 2009 |
July 17, 2008 |
April 16, 2013 |
April 16, 2013 |
- Sarcoma Oncology Center
Santa Monica, California, United States - Kootenai Cancer Center
Couer D' Alene, Idaho, United States - Nebraska Methodist Hospital
Omaha, Nebraska, United States
|
| 43 |
NCT03445013 |
Completed |
A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis |
|
- Drug: SB414 6%
- Drug: Vehicle
|
Interventional |
Phase 1 |
- Novan, Inc.
- Novella Clinical
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Plasma concentrations of hMAP3
- Safety Profile (Reported Adverse Events)
- Subject Assessment of Tolerability
- (and 4 more...)
|
36 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT03445013 |
NI-PS101 |
|
October 13, 2017 |
January 31, 2018 |
February 6, 2018 |
February 26, 2018 |
March 27, 2018 |
|
- Novella Site# 247
Boise, Idaho, United States - Novella Site# 183
Austin, Texas, United States - Novella Site# 249
College Station, Texas, United States - Novella Site# 114
Norfolk, Virginia, United States
|
| 44 |
NCT02375815 |
Completed |
Statin Choice Decision Aid Implementation First Phase |
- Cardiovascular Factor Risk
|
- Other: Statin Choice Implementation
|
Interventional |
Not Applicable |
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Effective Implementation of Statin Choice Decision Aid (SCDA), as indicated by the cumulative reach (% usage in appropriate primary care consultations) across all 3 health systems (as measured by EMR-based calculations).
|
313 |
All |
18 Years and older (Adult, Senior) |
NCT02375815 |
14-006048 |
SCIP1 |
January 2015 |
December 2016 |
March 2017 |
March 3, 2015 |
March 24, 2017 |
|
- Kootenai Health
Coeur d'Alene, Idaho, United States - Mayo Clinic in Rochester
Rochester, Minnesota, United States - Mosaic Life Care
St. Joseph, Missouri, United States - Altru Health System
Grand Forks, North Dakota, United States
|
| 45 |
NCT02696252 |
Completed |
G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator |
|
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- proportion of blood glucose values, compared between CGM and a lab glucose analyzer that are matched relative to a diabetes accuracy measurement of %20/20 mg/dL
|
97 |
All |
2 Years and older (Child, Adult, Senior) |
NCT02696252 |
PTL-901800 |
|
January 2016 |
April 2016 |
April 2016 |
March 2, 2016 |
April 14, 2016 |
|
- AMCR Institute
Escondido, California, United States - Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho, United States - Joslin Diabetes Center
Boston, Massachusetts, United States - Clinical Trials of Texas
San Antonio, Texas, United States
|
| 46 |
NCT02196818 |
Recruiting |
A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup |
- Osteoarthritis
- Arthritis
- Avascular Necrosis
- (and 2 more...)
|
- Device: Mpact Acetabular Shell
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- The Kaplan-Meier analysis as a measure of implant performance.
- The Harris Hip Score.
- Radiological analysis as a meausure of safety.
|
200 |
All |
Child, Adult, Senior |
NCT02196818 |
P01.014.08/00 |
|
March 2013 |
March 2023 |
March 2024 |
July 22, 2014 |
April 10, 2018 |
|
- Vail Orthopedics, P.C.
Denver, Colorado, United States - Saint Alphonsus Regional Medical Center
Boise, Idaho, United States - Illinois Bone & Joint Institute, LLC
Libertyville, Illinois, United States - Jordan Valley Medical Center
West Jordan, Utah, United States
|
| 47 |
NCT03257501 |
Completed |
FreeStyle Libre Flash Accuracy Study |
|
- Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- System Performance with respect to YSI reference venous plasma sample measurements.
- System Related adverse device effects
|
104 |
All |
18 Years and older (Adult, Senior) |
NCT03257501 |
ADC-US-VAL-17166 |
|
August 22, 2017 |
January 8, 2018 |
January 8, 2018 |
August 22, 2017 |
January 9, 2018 |
|
- William Sansum Diabetes Center
Santa Barbara, California, United States - Diablo Clinical Research
Walnut Creek, California, United States - Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States - Rainier Clinical Research
Renton, Washington, United States
|
| 48 |
NCT03159546 |
Completed |
FreeStyle Libre Flash Glucose Monitoring System Accuracy |
|
- Device: Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- System Performance
- System Related adverse device effects
|
50 |
All |
18 Years and older (Adult, Senior) |
NCT03159546 |
ADC-US-VAL-17165 |
|
May 13, 2017 |
July 18, 2017 |
August 24, 2017 |
May 18, 2017 |
September 6, 2017 |
|
- William Sansum Diabetes Center
Santa Barbara, California, United States - Diablo Clinical Research
Walnut Creek, California, United States - Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States - Rainier Clinical Research Center
Renton, Washington, United States
|
| 49 |
NCT03141892 |
Completed |
FreeStyle Libre Flash Glucose Monitoring System Accuracy Study |
|
- Device: FreeStyle Libre Flash Glucose Monitoring System
|
Observational |
|
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- System Performance
- System related adverse device effects and serious adverse effects
|
50 |
All |
18 Years and older (Adult, Senior) |
NCT03141892 |
ADC-US-VAL-17164 |
|
April 13, 2017 |
May 23, 2017 |
May 30, 2017 |
May 5, 2017 |
July 11, 2017 |
|
- William Sansum Diabetes Center
Santa Barbara, California, United States - Diablo Clinical Research
Walnut Creek, California, United States - Rocky Mountain Diabetes & Osteoporosis Center
Idaho Falls, Idaho, United States - Rainier Clinical Research Center
Renton, Washington, United States
|
| 50 |
NCT02662842 |
Completed |
BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study |
|
- Device: FlowSmart Infusion Set
- Device: Current Infusion Set
|
Observational |
|
- Becton, Dickinson and Company
- Medtronic
|
Industry |
- Observational Model: Case-Crossover
- Time Perspective: Prospective
|
- Comparative Infusion Set Insertion Pain
- Comparative Infusion Set Wear Comfort
- Overall Infusion Set Preference
|
75 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT02662842 |
DBC-15SCARL15 |
|
January 2016 |
February 2016 |
February 2016 |
January 26, 2016 |
April 13, 2017 |
|
- AMCR Institute Inc.
Escondido, California, United States - Atlanta Diabetes Associates
Atlanta, Georgia, United States - Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho, United States - TKL Research
Fair Lawn, New Jersey, United States
|
Create an RSS feed from your search for:
Download the search results for: